Mackenzie Financial Corp Sells 21,845 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Mackenzie Financial Corp reduced its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 16.8% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 108,127 shares of the company's stock after selling 21,845 shares during the quarter. Mackenzie Financial Corp's holdings in HCA Healthcare were worth $37,363,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in the business. Atwood & Palmer Inc. acquired a new position in HCA Healthcare in the first quarter worth $28,000. Bartlett & CO. Wealth Management LLC increased its holdings in shares of HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after acquiring an additional 80 shares in the last quarter. ORG Partners LLC increased its holdings in shares of HCA Healthcare by 344.0% in the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after acquiring an additional 86 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its holdings in shares of HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after buying an additional 50 shares in the last quarter. Finally, Legacy Investment Solutions LLC boosted its position in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after purchasing an additional 95 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

HCA has been the subject of a number of recent analyst reports. Guggenheim initiated coverage on HCA Healthcare in a research report on Wednesday, April 9th. They issued a "neutral" rating for the company. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Royal Bank Of Canada set a $401.00 target price on HCA Healthcare and gave the stock an "outperform" rating in a report on Monday. Barclays dropped their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research note on Monday. Finally, Wells Fargo & Company raised HCA Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price objective for the stock from $320.00 to $385.00 in a report on Thursday, May 29th. Nine equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $396.46.

HCA Healthcare Price Performance

HCA traded up $2.85 during trading on Friday, reaching $356.84. The stock had a trading volume of 1,369,756 shares, compared to its average volume of 1,609,565. The stock has a market cap of $85.84 billion, a PE ratio of 15.00, a PEG ratio of 1.12 and a beta of 1.47. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The business has a 50-day moving average of $371.06 and a 200-day moving average of $346.78.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The firm had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same period last year, the firm earned $5.50 earnings per share. The company's revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Insider Buying and Selling

In other news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.30% of the stock is owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.